Does a "one-stop" gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health?

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 279-284

  Wood, N J ^a   Munot, S ^a   Sheridan, E ^b   Duffy, S R ^a,b  

^a DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Anxiety; Cancer; Depression; Endometrial biopsy; Gynecology; HNPCC; Hysteroscopy; Perception of health; Screening; Ultrasound

Indexed keywords

CA 125 ANTIGEN;

ANXIETY; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; COLORECTAL CANCER; ECHOGRAPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FALSE POSITIVE RESULT; FAMILIAL CANCER; FEMALE; GYNECOLOGIC CANCER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYSTEROSCOPY; MORBIDITY; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; QUESTIONNAIRE; SHORT FORM 36; TRANSVAGINAL ECHOGRAPHY;

ADULT; ANXIETY; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DEPRESSION; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MASS SCREENING; PERCEPTION;

EID: 40549099758     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01009.x     Document Type: Article

References (34)

1. Stewart-Brown S, Farmer A. Screening could seriously damage your health. BMJ 1997 314 : 533.
2. Hendriks YM, Wagner A, Morreau H et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004 127 : 17 25.
3. Dunlop MG, Farrington SM, Carothers AD et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Gen 1997 6 : 105 10.
4. Vasen H, Wijnen J, Menko F et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996 110 : 1020 7.
5. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999 81 : 214 8.
6. Satagopan JM, Ben-Porat L, Berwick M et al. A note on competing risks in survival data analysis. Br J Cancer 2004 91 : 1229 35.
7. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000 118 : 829 34.
8. Dove-Edwin I, Boks D, Goff S et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002 94 : 1708 12.
9. Rijcken FEM, Mourits MJE, Kleibeuker JH et al. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003 91 : 74 80.
10. Robertson G. Screening for endometrial cancer. Med J Aust 2003 178 : 657 9.
11. Giorda G, Crivellari D, Veronesi A et al. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients. Acta Obstet Gynecol Scand 2002 81 : 975 80.
12. Epstein E, Ramirez A, Skoog L et al. Transvaginal sonography, saline contrast sonohysterography and hysteroscopy for the investigation of women with postmenopausal bleeding and endometrium > 5 mm. Ultrasound Obstet Gynecol 2001 18 : 157 62.
13. Garuti G, Cellani F, Grossi F et al. Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake. Gynecol Oncol 2002 86 : 323 9.
14. Clark TJ, Voit D, Gupta JK et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA: The Journal of the American Medical Association 2002 288 : 1610 21.
15. Vasen HF, Watson P, Mecklin JP et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999 116 : 1453 6.
16. Herrmann C. International experience with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 1997 42 : 17 41.
17. Ware J, Kosinski M, Dewey J. How to Score Version 2 of the SF-36 Health Survey. Lincoln, RI : QualityMetric Incorporated, 2000.
18. Marteau TM. Psychological costs of screening. BMJ 1989 299 : 527.
19. Marteau TM, Kidd J, Cook R et al. Screening for Down's syndrome. BMJ 1988 : 297 : 1469.
20. Cockburn J, Staples M, Hurley SF et al. Psychological consequences of screening mammography. J Med Screen 1994 1 : 7 12.
21. Wordsworth S, Ryan M, Skatun D et al. Women's preferences for cervical cancer screening: a study using a discrete choice experiment. Int J Technol Assess Health Care 2006 22 : 344 50.
22. Williams GL, Clarke P, Vellacott KD. Anxieties should not be forgotten when screening relatives of colorectal cancer patients by colonoscopy. Colorectal Disease 2006 8 : 781 4.
23. Collins V, Meiser B, Gaff C et al. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 2005 104 : 273 81.
24. Hodgson S, Bishop D, Dunlop M et al. Suggested screening guidelines for familial colorectal cancer. J Med Screening 1995 2 : 45 51.
25. Burke W, Petersen G, Lynch P et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997 277 : 915 9.
26. IGCS. International Collaborative Group - Hereditary Nonpolyposis Colorectal Cancer. Available at : http://wwwnfdhtnl/ 2004 (Accessed June 2006).
27. Baxter NP, Duffy SR, Sheridan E. Endometrial abnormalities in three sisters from a family with hereditary non-polyposis colorectal cancer syndrome. BJOG 2002 109 : 1076 8.
28. Rogerson L, Bates J, Weston M et al. A comparison of outpatient hysteroscopy with saline infusion hysterosonography. BJOG 2002 109 : 800 4.
29. Crosignani PG, Vercellini P, Apolone G et al. Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. Am J Obstet Gynecol 1997 177 : 95 101.
30. Spinhoven P, Ormel J, Sloekers PP et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997 27 : 363 70.
31. Smith AB, Selby PJ, Velikova G et al. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother 2002 75 (Pt 2 165 76.
32. Ekeberg O, Skjauff H, Karesen R. Screening for breast cancer is associated with a low degree of psychological distress. Breast 2001 10 : 20 4.
33. Katz DA, Jarrard DF, McHorney CA et al. Health perceptions in patients who undergo screening and workup for prostate cancer. Urology 2007 69 : 215 20.
34. Dunlop MG, Farrington SM, Nicholl I et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 2000 83 : 1643 5.